Charles Schwab Investment Management »

Design Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $466k 176k 2.65
2023-09-30 $410k 174k 2.36
2023-06-30 $1.4M 229k 6.30
2023-03-31 $1.3M 230k 5.77
2022-12-31 $2.4M 231k 10.26
2022-09-30 $3.8M 225k 16.72
2022-06-30 $1.9M 135k 14.00
2022-03-31 $2.0M 122k 16.16
2021-12-31 $2.5M 119k 21.42
2021-09-30 $1.3M 91k 14.69
2021-06-30 $1.7M 88k 19.89